Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes
Article Information
vol. 36 no. 7 2077-2083
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 12, 2012
- Accepted January 2, 2013
- Published in print June 25, 2013.
- Published online ahead of print February 1, 2013.
Article Versions
- Previous version (February 1, 2013 - 13:45).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
Author Information
- Nicolae M. Panduru, MD, PHD1,2,
- Carol Forsblom, DMSC2,3,
- Markku Saraheimo, MD, DMSC2,3,
- Lena Thorn, MD, DMSC2,3,
- Angelika Bierhaus, PHD4,†,
- Per M. Humpert, PHD5,
- Per-Henrik Groop, MD, DMSC2,3,6⇑,
- on behalf of the FinnDiane Study Group*
- 1Second Clinical Department, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
- 2Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland
- 3Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
- 4Department of Medicine I and Clinical Chemistry, University of Heidelberg, Heidelberg, Germany
- 5Stoffwechselzentrum Rhein Pfalz, Mannheim, Germany
- 6Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
- Corresponding author: Per-Henrik Groop, per-henrik.groop{at}helsinki.fi.
P.M.H. and P.-H.G. contributed equally to this work.
Statistics from Altmetric.com
Article usage
Current Issue
March 2021
Volume 44, Issue 3
Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes
